ABH001

· Shire Regenerative Medicine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABH001, covering 2013-11-21 to 2013-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing [Phase 3]

See pricing